Safety inspection method for ursodesoxycholic acid raw material
Through the safety inspection methods of ursodeoxycholic acid raw materials, including the preparation of test sample solutions and animal model testing, the problem of lack of safety inspection methods is solved, ensuring the safety and quality of the injections are controllable, and providing reliable testing standards are provided and method.
Patent Information
- Application Number
- CN202411004039.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-12
Smart Images

Figure BDA0004962480370000052 
Figure BDA0004962480370000061 
Figure BDA0004962480370000062
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of injection safety inspection, and in particular to a safety inspection method for ursodeoxycholic acid raw materials. Background Art
[0002] Ursodeoxycholic acid (UDCA), chemically known as 3α,7β-dihydroxy-5β-cholestane-24-acid, is a steroid compound in bear bile. It is odorless and bitter. Ursodeoxycholic acid is a multifunctional hydrophilic bile acid and one of the important drugs for the treatment of cholestatic liver disease. At present, ursodeoxycholic acid raw materials are mainly used as auxiliary ingredients in oral preparations, including capsules and tablets, and there are no reports on ursodeoxycholic acid directly used as raw materials to make intravenous injections.
[0003] According to the application guidelines of the safety inspection method for injections in Part IV 9301 of the 2020 edition of the Chinese Pharmacopoeia, when the raw materials used are of animal or plant origin, safety inspection items should be established, including abnormal toxicity inspection, allergic reaction inspection, antihypertensive substance inspection, etc. Therefore, the present invention aims to establish a safety inspection method for ursodeoxycholic acid raw materials and provides the standards for each safety inspection item. Summary of the invention
[0004] The present invention is to use ursodeoxycholic acid as a raw material to prepare an intravenous injection, but there is a lack of safety inspection methods and standards. The purpose of the present invention is to provide a safety inspection method for ursodeoxycholic acid raw materials, which provides a basis for the safety of ursodeoxycholic acid injection and the controllability of preparation quality. After process verification, the inspection results of each item are in compliance with the regulations, and the established detection standards and methods are reliable.
[0005] The present invention is achieved through the following technical solutions:
[0006] The present invention provides a safety inspection method for ursodeoxycholic acid raw materials, comprising the following steps:
[0007] Prepare the test solution: add sterile water for injection to the test ursodeoxycholic acid API, and then add sodium hydroxide test solution to completely dissolve it, and filter it with a filter membrane to obtain the test solution;
[0008] Acute toxicity test: Prepare ursodeoxycholic acid test solutions of different concentrations based on the above steps, perform tail vein injection on mice, determine the maximum lethal dose and maximum safe dose, group them according to the maximum safe injection dose and the maximum lethal dose, perform tail vein injection on mice, and calculate the LD based on the results. 50 Values and their 95% confidence intervals;
[0009] Abnormal toxicity test: by LD 50The abnormal toxicity test limit was obtained based on the value, and the ursodeoxycholic acid test solution was prepared according to the abnormal toxicity test limit, and the solution was injected into the tail vein of mice for abnormal toxicity test;
[0010] Allergic reaction test: Set the allergic reaction test limit as the maximum safe dose of ursodeoxycholic acid for intravenous injection, prepare the ursodeoxycholic acid test solution according to the allergic reaction test limit, and then inject it into guinea pigs for allergic reaction test;
[0011] Antihypertensive substance inspection: According to the abnormal toxicity inspection limit of mice and the equivalent dose coefficient conversion method, the abnormal toxicity limit of cats is obtained and set as the antihypertensive substance inspection limit. The antihypertensive substance inspection is performed by injection at 0.2 to 1 times the antihypertensive substance inspection limit;
[0012] Pressor substance inspection: Based on the abnormal toxicity inspection limit for mice and the equivalent dose coefficient conversion method, the abnormal toxicity limit for rats is obtained and set as the pressor substance inspection limit. Injections are performed at 0.2 to 1 times the pressor substance inspection limit for pressor substance inspection.
[0013] In the present invention, the concentrations of the test solutions used in different test items are different and need to be prepared and used immediately.
[0014] The present invention determines the conditions required for the dissolution of ursodeoxycholic acid based on its solubility characteristics, thereby preparing a test solution with a matching concentration, laying the foundation for determining the limit values of different inspection items. Then, the LD 50 and its 95% confidence interval, thereby determining the abnormal toxicity limit and allergic reaction limit; and converting the abnormal toxicity limit of mice into the abnormal toxicity limits of cats and rats respectively to determine the antihypertensive substance inspection limit and pressor substance inspection limit. Finally, three batches of sample process verification were carried out to determine that the established detection method is feasible.
[0015] Further, the specific process of preparing the test solution is as follows:
[0016] Add sterile water for injection to the test sample ursodeoxycholic acid API, then sonicate for 4 to 8 hours. Add 0.1 mol / L sodium hydroxide solution in small amounts several times. After each addition of sodium hydroxide, shake and mix thoroughly, sonicate for 15 to 20 minutes to completely dissolve the test sample. At this time, the pH of the test sample solution is 7.5 to 9.0.
[0017] After adding sterile water for injection to the test sample ursodeoxycholic acid raw material, the present invention needs to be ultrasonicated for 4 to 8 hours, and the ursodeoxycholic acid raw material is crushed to fully contact with the sterile water for injection, and dissolved by further treatment; the ursodeoxycholic acid raw material is easily soluble in ethanol, insoluble in chloroform, easily soluble in glacial acetic acid, and dissolved in sodium hydroxide test solution. According to the characteristics of ursodeoxycholic acid and avoiding interference from exogenous substances, the present invention adopts 0.1 mol / L sodium hydroxide solution for dissolution; in addition, sterile water for injection with a pH of 5.0 to 7.0 is used for dissolution to avoid the high pH value of the solvent causing the pH of ursodeoxycholic acid to be too high when it is finally dissolved. In addition, the injection pH value is usually between 4.0 and 9.0. Under this condition, the pH range of the ursodeoxycholic acid solution is set to 7.5 to 9.0. The amount of sodium hydroxide needs to be strictly controlled during the dissolution process, and the dissolution state is observed after sufficient mixing to avoid the excess sodium hydroxide from reacting with ursodeoxycholic acid and causing the solution pH to be too high.
[0018] Furthermore, filtration was performed using a 0.22 μm pore size filter membrane.
[0019] Furthermore, the maximum safe dose of ursodeoxycholic acid by intravenous injection is 150 mg / kg, and the maximum lethal dose is 425 mg / kg.
[0020] Furthermore, the acute toxicity LD 50 The value is 267.793 mg / kg.
[0021] Furthermore, the abnormal toxicity test limit for mice was 30.17 mg / kg.
[0022] Furthermore, the limit of allergic reaction test in guinea pigs is 150 mg / kg.
[0023] As long as the injection contains allergic substances, it can cause allergic reactions, regardless of the dose of the test article. The sensitization and stimulation doses should be less than the acute toxicity dose of the administration route.
[0024] Furthermore, the inspection limit for antihypertensive substances is 90.51 mg / kg.
[0025] Furthermore, the inspection limit for pressor substances is 42.238 mg / kg.
[0026] Furthermore, the abnormal toxicity limit for cats = the abnormal toxicity limit for mice * the weight of cats * the conversion factor, and the abnormal toxicity limit for rats = the abnormal toxicity limit for mice * the weight of rats * the conversion factor.
[0027] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0028] 1. The present invention provides a basis for the safety of ursodeoxycholic acid injection and the controllability of preparation quality by establishing a safety inspection method and standard for ursodeoxycholic acid raw materials. The inspection results of each item after process verification are in compliance with the regulations, and the established inspection standards and methods are reliable.
[0029] 2. In the present invention, after adding the ursodeoxycholic acid raw material into an appropriate amount of sterile water for injection, ultrasonic treatment is first performed for 4-8 hours, and after the ursodeoxycholic acid is fully crushed, sodium hydroxide solution is added to dissolve it, thereby solving the solubility problem of the ursodeoxycholic acid raw material. DETAILED DESCRIPTION
[0030] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with embodiments. The illustrative embodiments of the present invention and their description are only used to explain the present invention and are not intended to limit the present invention.
[0031] Example 1
[0032] A safety inspection method for ursodeoxycholic acid raw materials comprises the following steps:
[0033] S1. Prepare the test solution:
[0034] S11. Add sterile water for injection to the test sample ursodeoxycholic acid API, then ultrasonicate (40KHz) for 4-8h, add 0.1mol / L sodium hydroxide solution in small amounts several times, shake and mix each time, then ultrasonicate for 15-20min to completely dissolve the test sample. At this time, the pH of the test sample solution is 7.5-9.0;
[0035] S12, preparing test sample solutions for different test items based on the method of step S11;
[0036] The concentrations of test solutions used in different test items are different and need to be prepared and used immediately. All test solutions must be filtered through a 0.22μm pore size filter membrane before use.
[0037] S2. Acute toxicity test:
[0038] Acute toxicity preliminary test: Intravenous injection of mice at different concentrations (uniform injection within 4-5 seconds) determined that the maximum safe dose was 150 mg / kg and the maximum lethal dose was 425 mg / kg;
[0039] Acute toxicity formal test: according to the maximum safe injection dose and the maximum lethal dose, six dose groups and one control group were set up, and mice were injected intravenously (injected at a constant speed within 4-5s), and the LD was calculated based on the results. 50 267.793 mg / kg, LD 50The 95% confidence interval is 241.39 mg / kg ≤ LD 50 ≤297.084mg / kg.
[0040] S3. Abnormal toxicity test:
[0041] Take 30.17 mg / kg as the abnormal toxicity test limit, and perform abnormal toxicity test (inject at a constant speed within 4-5 seconds) at 30.17 mg / kg (0.5 ml / animal according to the abnormal toxicity test method).
[0042] S4. Allergic reaction test:
[0043] The injection is carried out at 150 mg / kg. The test standard is that no allergic reaction should occur within 30 minutes of intravenous injection of the test solution.
[0044] S5. Antihypertensive substance inspection:
[0045] The antihypertensive substance test was performed according to 0.2 to 1 times (gradient of 0.2, 0.4, 0.6, 0.8, 1 times) of the abnormal toxicity limit of 90.51 mg / kg for cats. The injection volume of the test solution and the histamine reference solution was the same (0.2 ml / kg).
[0046] S6. Check for pressor substances:
[0047] The injection was performed at 0.2 to 1 times (with a gradient of 0.2, 0.4, 0.6, 0.8, and 1 times) the abnormal toxicity limit of 42.238 mg / kg in rats, and the injection volume was the same as the administration volume of the standard product.
[0048] According to the 2020 edition of the Chinese Pharmacopoeia, the applicability of this method was confirmed. The specific application process of this embodiment is as follows:
[0049] Verification test of safety inspection standards and methods for ursodeoxycholic acid raw materials:
[0050] 1. Preparation of test solution
[0051] 1. Preparation method of test solution for acute toxicity test:
[0052] Dose group 1 (0.6%): i.e. 150 mg / kg, weigh 0.600 g of the test substance ursodeoxycholic acid, add 100 ml of water for injection, add 0.1 mol / L sodium hydroxide solution in small amounts several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0053] Dose group 2 (0.74%): i.e. 185 mg / kg, weigh 0.740 g of the test substance ursodeoxycholic acid, add 100 ml of water for injection, add 0.1 mol / L sodium hydroxide solution in small amounts several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0054] Dose group 3 (0.91%): i.e. 227.5 mg / kg, weigh 0.910 g of the test ursodeoxycholic acid raw material, add 100 ml of water for injection, add 0.1 mol / L sodium hydroxide solution in small amounts several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0055] Dose group 4 (1.12%): i.e. 280 mg / kg, weigh 1.120 g of the test substance ursodeoxycholic acid, add 100 ml of water for injection, add 0.1 mol / L sodium hydroxide solution in small amounts several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0056] Dose group 5 (1.38%): i.e. 345 mg / kg, weigh 1.380 g of the test substance ursodeoxycholic acid, add 100 ml of water for injection, add 0.1 mol / L sodium hydroxide solution in small amounts several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0057] Dose group 6 (1.7%): i.e. 425 mg / kg, weigh 1.700 g of the test substance ursodeoxycholic acid, add 100 ml of water for injection, add 0.1 mol / L sodium hydroxide solution in small amounts several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0058] 2. Preparation method of test solution for abnormal toxicity test:
[0059] Test solution: 30.17 mg / kg, weigh 0.121 g of the test substance ursodeoxycholic acid, add 100 ml of water for injection, add 0.1 mol / L sodium hydroxide solution in small amounts several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0060] 3. Preparation method of test solution for allergic reaction test:
[0061] Test solution (0.6%): i.e. 150 mg / kg, weigh 0.600 g of the test substance ursodeoxycholic acid raw material and add 100 ml of water for injection, add 0.1 mol / L sodium hydroxide solution in small amounts several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0062] 4. Preparation method of test solution for antihypertensive substance examination:
[0063] Test solution: 90.51 mg / kg, weigh 0.362 g of the test substance ursodeoxycholic acid raw material, add 100 ml of water for injection, take 0.1 mol / L sodium hydroxide solution in small amounts and add it several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0064] 5. Preparation of test solution for pressor substance examination:
[0065] Test solution: 42.238 mg / kg, weigh 0.169 g of the test substance ursodeoxycholic acid raw material, add 100 ml of water for injection, take 0.1 mol / L sodium hydroxide solution in small amounts and add it several times, mix well, and then ultrasonicate for 15 to 20 minutes until the ursodeoxycholic acid is completely dissolved.
[0066] 2. Acute toxicity test
[0067] Acute toxicity pre-test: First, the quarantine qualified mice were randomly divided into groups, 10 mice / group, and three replicates were set for each dose (concentration gradient was 0.1%). The experimental results showed that when the intravenous injection dose was 425 mg / kg, all mice died; when the intravenous injection dose was 150 mg / kg, no mice died.
[0068] Acute toxicity formal test: The design range of this test dose is set from the maximum safe dose (150mg / kg) to the maximum lethal dose (425mg / kg). According to the formula The geometric ratio r between the doses was calculated to be 1.232, and the doses and groups of each group were obtained, see Table 1.
[0069] Table 1. Doses and groups in acute toxicity test
[0070]
[0071] The survival of the animals was observed within 72 hours after administration. The results are shown in Table 2.
[0072] Table 2. Survival of animals within 72 hours after administration
[0073]
[0074] The experimental results showed that within 3 days after administration, no mice died in dose group 1 (150 mg / kg) and the control group (sterile water for injection pH = 9.02), 1, 2, 5, and 8 mice died in dose groups 2 (185 mg / kg), 3 (227.5 mg / kg), 4 (280 mg / kg), and 5 (345 mg / kg), respectively, and all mice in dose group 6 (425 mg / kg) died.
[0075] The results of the formal acute toxicity test in mice showed that the maximum safe dose of ursodeoxycholic acid for intravenous injection is 150 mg / kg, and the maximum lethal dose is 425 mg / kg. According to the experimental results, the acute toxicity LD 50 The value is 267.793 mg / kg, LD 50 The 95% confidence interval is 241.39 mg / kg ≤ LD 50 ≤297.084mg / kg, so the abnormal toxicity inspection limit of this test is 30.17mg / kg.
[0076] 3. Abnormal toxicity test
[0077] The results of the acute toxicity experiment on mice showed that the maximum safe dose of ursodeoxycholic acid for intravenous injection is 150 mg / kg, and the maximum lethal dose is 425 mg / kg. According to the experimental results, the acute toxicity LD 50 The value is 267.793mg / kg, LD 50 The 95% confidence interval is 241.39 mg / kg ≤ LD 50 ≤297.084 mg / kg. The present invention takes 30.17 mg / kg as the abnormal toxicity inspection limit. Set test samples 1-3 to represent 3 independent inspection batches that are different between experiments, and according to the verification requirements, it needs to be carried out 3 times, and the results are shown in Table 3.
[0078] Table 3. Abnormal toxicity verification results
[0079]
[0080]
[0081] As can be seen from Table 3, after three batches of sample process verification, it was determined that the safety inspection method of the present invention is feasible, and taking 30.17 mg / kg as the abnormal toxicity inspection limit is reliable.
[0082] 4. Allergic reaction test
[0083] Since the sensitization and stimulation doses should be less than the acute toxicity dose of this route of administration. Therefore, combined with the results of the mouse acute toxicity preliminary test, the maximum safe intravenous dose of ursodeoxycholic acid is 150 mg / kg, and the allergic reaction test limit is set to 150 mg / kg. The detection standard is that no allergic reaction should occur within 30 minutes of intravenous injection of the test solution. Test samples 1-3 are set to represent 3 independent test batches between experiments. According to the verification requirements, it needs to be carried out 3 times, and the results are shown in Table 4.
[0084] Table 4. Allergic reaction verification results
[0085]
[0086]
[0087] As can be seen from Table 4, after three batches of sample process verification, it was determined that the safety inspection method of the present invention is feasible, and setting the allergic reaction inspection limit at 150 mg / kg is reliable.
[0088] 5. Blood pressure lowering substance inspection
[0089] Since there is no clinical single dose for ursodeoxycholic acid raw material, the reference mouse abnormal toxicity limit is 30.17 mg / kg. According to the equivalent dose coefficient conversion method in "Pharmacological Experimental Methodology", the cat abnormal toxicity limit (mg / kg) = mouse abnormal toxicity limit (mg / kg) * cat body weight * conversion coefficient (mice: cat = 1:0.03) / 20g (standard mouse body weight). Therefore, in order to ensure that the injection dose is within the safety range, the concentration of this experiment was set at 0.2 to 1 times the cat abnormal toxicity limit (gradient of 0.2, 0.4, 0.6, 0.8, 1 times), and the administration volume was 0.2 ml / kg, which is the same as the administration volume of the standard product. It is concluded that the maximum dose of the test product antihypertensive substance test meets the regulations (maximum dose without antihypertensive reaction), that is, the antihypertensive substance inspection limit is 90.51 mg / kg.
[0090] According to the requirements of the antihypertensive substance inspection method, the sensitivity of cats needs to be confirmed. Table 5 shows the sensitivity test results of cats.
[0091] Test samples 1-3 represent three independent test batches between different laboratories. According to the validation requirements, the test needs to be carried out three times. Histamine phosphate was used as a control. The results are shown in Table 6, which proves that the detection limit of antihypertensive substances is 90.51 mg / kg with reliability.
[0092] Table 5. Results of sensitivity test for cats
[0093]
[0094] Table 6. Validation results of antihypertensive substances
[0095]
[0096]
[0097] 6. Test for pressor substances
[0098] Since there is no clinically prescribed limit for ursodeoxycholic acid raw materials, the mouse abnormal toxicity limit of 30.17 mg / kg is used as a reference. According to the equivalent dose coefficient conversion method in "Pharmacological Experimental Methodology", the rat abnormal toxicity limit (mg / kg) = mouse abnormal toxicity limit (mg / kg) * rat body weight (200g) * conversion coefficient (mice: cat = 1:0.14) / 20g (standard mouse body weight) = 42.238 mg / kg. Therefore, in order to ensure that the injection dose is within the safety range, the concentration of this experiment is set at 0.2 to 1 times (gradient of 0.2, 0.4, 0.6, 0.8, 1 times) of the rat abnormal toxicity limit of 42.238 mg / kg, and the injection volume is the same as the standard dosage volume. It is concluded that the pressor substance test of the test article meets the prescribed maximum dose (maximum dose without pressor response), that is, the pressor substance inspection limit is set to 42.238 mg / kg.
[0099] According to the requirements of the pressor substance inspection method, the sensitivity of rats needs to be confirmed. Table 7 shows the sensitivity test results of rats used for test sample 1, Table 8 shows the verification results of test sample 1, Table 9 shows the sensitivity test results of rats used for test samples 2 and 3, and Table 10 shows the verification results of test samples 2 and 3.
[0100] Table 7. Results of the sensitivity test on rats used for test sample 1
[0101]
[0102] Table 8. Verification results of sample 1
[0103]
[0104]
[0105] Table 9. Results of sensitivity test on rats used for test samples 2 and 3
[0106]
[0107] Table 10. Verification results of samples 2 and 3
[0108]
[0109] VII. Conclusion
[0110] 1. Acute toxicity test in mice:
[0111] (1) Test results
[0112] No mice died in dose group 1 (150 mg / kg) and control group (sterile water for injection pH = 9.02), 1, 2, 5, and 8 mice died in dose groups 2 (185 mg / kg), 3 (227.5 mg / kg), 4 (280 mg / kg), and 5 (345 mg / kg), respectively, and all mice died in dose group 6 (425 mg / kg).
[0113] (2) Calculation results
[0114] LD 50 The value is 267.793 mg / kg, LD 50 The 95% confidence interval is 241.39 mg / kg ≤ LD 50 ≤297.084mg / kg.
[0115] (3) Setting limit
[0116] 1. In this test, 30.17 mg / kg is taken as the abnormal toxicity detection limit.
[0117] 2. An abnormal toxicity test (injected at a constant speed within 4-5s) was carried out at 30.17mg / kg (0.5ml / mouse according to the abnormal toxicity test method). The results of the abnormal toxicity test of three batches of samples in process verification met the requirements, and the established testing standards and methods are feasible.
[0118] 3. Allergic reaction tests were conducted according to the maximum safe injection dose of 150 mg / kg. Three batches of samples for process verification were administered by intraperitoneal injection for sensitization and intravenous injection for stimulation. The results were in compliance with the regulations and the established detection standards and methods are feasible.
[0119] 4. The antihypertensive substance inspection was carried out according to 90.51 mg / kg. The inspection results of antihypertensive substances in three batches of samples for process verification were in compliance with the regulations. The established testing standards and methods are feasible.
[0120] 5. The pressor substance inspection was carried out at 42.238 mg / kg, and the pressor substance inspection results of three batches of samples for process verification were in compliance with the regulations. The established testing standards and methods are feasible.
[0121] The specific implementation methods described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above description is only a specific implementation method of the present invention and is not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. A method for inspecting the safety of ursodeoxycholic acid raw materials, characterized in that: The following steps are involved: Prepare the test solution: add sterile water for injection to the test ursodeoxycholic acid API, and add sodium hydroxide test solution to completely dissolve it, and filter it with a filter membrane to obtain the test solution; Acute toxicity test: Based on the above steps, different concentrations of ursodeoxycholic acid test solutions were prepared and injected into the tail vein of mice to determine the maximum lethal dose and the maximum safe dose. Mice were grouped according to the maximum safe injection dose and the maximum lethal dose, and intravenously injected into mice. The acute toxicity LD of mice was calculated based on the results. 50 ; Abnormal toxicity test: by LD 50 The abnormal toxicity test limit was obtained based on the value, and the ursodeoxycholic acid test solution was prepared according to the abnormal toxicity test limit, and the solution was injected into the tail vein of mice for abnormal toxicity test; Allergic reaction test: Set the allergic reaction test limit as the maximum safe dose of ursodeoxycholic acid for intravenous injection, prepare the ursodeoxycholic acid test solution according to the allergic reaction test limit, and then inject it into guinea pigs for allergic reaction test; Antihypertensive substance inspection: According to the abnormal toxicity inspection limit of mice and the equivalent dose coefficient conversion method, the abnormal toxicity limit of cats is obtained and set as the antihypertensive substance inspection limit. The antihypertensive substance inspection is performed by injection at 0.2 to 1 times the antihypertensive substance inspection limit; Pressor substance inspection: Based on the abnormal toxicity inspection limit for mice and the equivalent dose coefficient conversion method, the abnormal toxicity limit for rats is obtained and set as the pressor substance inspection limit. Injections are performed at 0.2 to 1 times the pressor substance inspection limit for pressor substance inspection.
2. The method for safety inspection of ursodeoxycholic acid raw materials according to claim 1, characterized in that: The specific process of preparing the test solution is as follows: Add sterile water for injection to the test sample ursodeoxycholic acid API, then sonicate for 4 to 8 hours. Add 0.1 mol / L sodium hydroxide solution in small amounts several times. After each addition of sodium hydroxide, shake and mix thoroughly, sonicate for 15 to 20 minutes to completely dissolve the test sample. At this time, the pH of the test sample solution is 7.5 to 9.
0.
3. The method for safety inspection of ursodeoxycholic acid raw material according to claim 1, characterized in that: Filtration was performed using a 0.22 μm pore size filter membrane.
4. The method for safety inspection of ursodeoxycholic acid raw material according to claim 1, characterized in that: The maximum safe dose of ursodeoxycholic acid by intravenous injection is 150 mg / kg, and the maximum lethal dose is 425 mg / kg.
5. The method for safety inspection of ursodeoxycholic acid raw material according to claim 1, characterized in that: Acute toxicity in mice LD 50 The value is 267.793 mg / kg.
6. The method for safety inspection of ursodeoxycholic acid raw material according to claim 5, characterized in that: The abnormal toxicity test limit for mice is 30.17 mg / kg.
7. The method for safety inspection of ursodeoxycholic acid raw material according to claim 1, characterized in that: The limit of allergic reaction test in guinea pigs is 150 mg / kg.
8. The method for safety inspection of ursodeoxycholic acid raw material according to claim 1, characterized in that: The inspection limit for antihypertensive substances is 90.51 mg / kg.
9. The method for safety inspection of ursodeoxycholic acid raw material according to claim 1, characterized in that: The inspection limit for pressor substances is 42.238 mg / kg.
10. The method for safety inspection of ursodeoxycholic acid raw material according to claim 1, characterized in that: The abnormal toxicity limit for cats = abnormal toxicity limit for mice * cat weight * conversion factor; the abnormal toxicity limit for rats = abnormal toxicity limit for mice * rat weight * conversion factor.
